{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:15Z","timestamp":1791300495686,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1525,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/art.30344","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T12:26:30Z","timestamp":1299846390000},"page":"1961-1971","source":"Crossref","is-referenced-by-count":208,"title":["Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy"],"prefix":"10.1002","volume":"63","author":[{"given":"Olivier","family":"Benveniste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Drouot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Charuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Bloch-Queyrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Behin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Guiguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Herson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Musset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,29]]},"reference":[{"key":"10.1002\/art.30344-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB2|cit2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/art.30344-BIB3|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB5|cit5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/art.30344-BIB6|cit6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB7|cit7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/art.30344-BIB8|cit8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/art.30344-BIB9|cit9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/art.30344-BIB10|cit10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10165-008-0139-8","article-title":"Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies","volume":"19","author":"Takada","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1002\/art.30344-BIB11|cit11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":"Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1002\/art.30344-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","article-title":"Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies","volume":"47","author":"Suzuki","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30344-BIB13|cit13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature08870","article-title":"Recognition of a signal peptide by the signal recognition particle","volume":"465","author":"Janda","year":"2010","journal-title":"Nature"},{"key":"10.1002\/art.30344-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.138.10.3219","article-title":"Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle","volume":"138","author":"Okada","year":"1987","journal-title":"J Immunol"},{"key":"10.1002\/art.30344-BIB15|cit15","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/art.30344-BIB16|cit16","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","article-title":"Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages","volume":"8","author":"Romisch","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30344-BIB17|cit17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1002\/art.30344-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB19|cit19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB20|cit20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB21|cit21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1002\/art.30344-BIB22|cit22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clim.2006.03.007","article-title":"Analysis of human sera that are polyreactive in an addressable laser bead immunoassay","volume":"120","author":"Fritzler","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1002\/art.30344-BIB23|cit23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jim.2008.02.022","article-title":"Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins","volume":"335","author":"Verkaik","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1002\/art.30344-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1002\/art.30344-BIB25|cit25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10067-004-1027-z","article-title":"Clinical significance of von Willebrand factor in patients with adult dermatomyositis","volume":"24","author":"Komiya","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1002\/art.30344-BIB26|cit26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/ard.47.9.717","article-title":"Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides","volume":"47","author":"Isenberg","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB27|cit27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.1780270203","article-title":"Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus","volume":"27","author":"Isenberg","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB28|cit28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/ard.2007.083030","article-title":"EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints","volume":"68","author":"Bertsias","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB29|cit29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1002\/art.30344-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/ard.2008.094714","article-title":"Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides","volume":"68","author":"Terrier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB31|cit31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/40.2.147","article-title":"Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study","volume":"40","author":"Girard","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30344-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30344-BIB33|cit33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1002\/art.30344-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1002\/art.30344-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","article-title":"Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNF\u03b1 therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement","volume":"63","author":"Alessandri","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30344-BIB37|cit37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00296-004-0571-9","article-title":"Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment","volume":"26","author":"Caramaschi","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1002\/art.30344-BIB38|cit38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1002\/art.30344-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/art.30344-BIB40|cit40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/art.30344-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1002\/art.30344-BIB42|cit42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis","volume":"247","author":"Sharshar","year":"2000","journal-title":"J Neurol"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30344","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30344\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:55:09Z","timestamp":1712274909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,29]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30344","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,29]]}}}